Study to Evaluate the Leish-111f + MPL-SE Vaccine in Healthy Adults Not Previously Exposed to Leishmania Parasite
NCT00121862
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Cutaneous Leishmaniasis
Interventions
BIOLOGICAL:
Leish-111f + MPL-SE vaccine
Sponsor
Access to Advanced Health Institute (AAHI)
Collaborators
[object Object]